Filana Therapeutics, Inc.
Austin, TX Cassava Sciences Inc.
- UEI
- ZENEXUHPHMJ3
- CAGE
- 49XX9
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 6801 N Capital of Texas Hwy, Austin, TX 78731, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Food effect study and drug supply scale-up for PTI-125 - project summary/abstract PTI-125 (sumifilam) is a novel small… | National Institute on Aging | $8,130,660 | |
| Open-label extension of a 3-month blinded clinical trial of PTI-125 | National Institute on Aging | $2,499,896 | |
| Development of PTI-125-DX, a blood-based diagnostic for alzheimer's disease | National Institute on Aging | $1,559,890 | |
| Extending clinical trial in ad patients from 1 to 3 months | National Institute on Aging | $3,906,146 | |
| Preformulation and formulation development of fenrock, an abuse-resistant fentanyl transdermal patch | National Institute on Drug Abuse | $2,166,090 |
Quick answers
What is Filana Therapeutics, Inc.'s UEI?
Filana Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is ZENEXUHPHMJ3.
What is Filana Therapeutics, Inc.'s CAGE code?
Filana Therapeutics, Inc.'s CAGE code is 49XX9.
What is Filana Therapeutics, Inc.'s primary NAICS code?
Filana Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Filana Therapeutics, Inc. located?
Filana Therapeutics, Inc.'s physical address in SAM.gov is 6801 N Capital of Texas Hwy, Austin, TX 78731, USA.
Is Filana Therapeutics, Inc. registered in SAM.gov?
Yes. Filana Therapeutics, Inc.'s SAM.gov registration is active through April 13, 2027.
What is Filana Therapeutics, Inc.'s most recent federal award?
Filana Therapeutics, Inc.'s most recent federal grant award is Food effect study and drug supply scale-up for PTI-125 - project summary/abstract PTI-125 (sumifilam) is a novel small… (R01AG067972), from National Institute on Aging, on May 15, 2021.
On GovTribe
See Filana Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors